PortfoliosLab logoPortfoliosLab logo
GPCR vs. ABAT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GPCR vs. ABAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Structure Therapeutics Inc. American Depositary Shares (GPCR) and American Battery Technology Company Common Stock (ABAT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GPCR achieves a -34.57% return, which is significantly lower than ABAT's -12.28% return.


GPCR

1D
2.25%
1M
16.13%
YTD
-34.57%
6M
-28.05%
1Y
109.43%
3Y*
15.78%
5Y*
10Y*

ABAT

1D
-6.09%
1M
-9.29%
YTD
-12.28%
6M
-29.57%
1Y
130.71%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GPCR vs. ABAT - Yearly Performance Comparison


2026 (YTD)202520242023
GPCR
Structure Therapeutics Inc. American Depositary Shares
-34.57%156.45%-33.46%16.79%
ABAT
American Battery Technology Company Common Stock
-12.28%35.77%-47.55%-60.25%

Correlation

The correlation between GPCR and ABAT is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Sep 21, 2023

0.17

Fundamentals

Market Cap

GPCR:

$3.30B

ABAT:

$386.34M

EPS

GPCR:

-$2.75

ABAT:

-$0.55

PB Ratio

GPCR:

2.28

ABAT:

3.43

Total Revenue (TTM)

GPCR:

$0.00

ABAT:

$16.28M

Gross Profit (TTM)

GPCR:

$0.00

ABAT:

-$6.95M

EBITDA (TTM)

GPCR:

-$191.27M

ABAT:

-$62.40M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GPCR vs. ABAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GPCR
GPCR Risk / Return Rank: 7878
Overall Rank
GPCR Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
GPCR Sortino Ratio Rank: 9090
Sortino Ratio Rank
GPCR Omega Ratio Rank: 8585
Omega Ratio Rank
GPCR Calmar Ratio Rank: 7373
Calmar Ratio Rank
GPCR Martin Ratio Rank: 7171
Martin Ratio Rank

ABAT
ABAT Risk / Return Rank: 7272
Overall Rank
ABAT Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
ABAT Sortino Ratio Rank: 7878
Sortino Ratio Rank
ABAT Omega Ratio Rank: 7676
Omega Ratio Rank
ABAT Calmar Ratio Rank: 7272
Calmar Ratio Rank
ABAT Martin Ratio Rank: 6464
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GPCR vs. ABAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Structure Therapeutics Inc. American Depositary Shares (GPCR) and American Battery Technology Company Common Stock (ABAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GPCRABATDifference
Sharpe ratioReturn per unit of total volatility

-0.07

Sortino ratioReturn per unit of downside risk

+1.08

Omega ratioGain probability vs. loss probability

1.35

1.26

+0.10

Calmar ratioReturn relative to maximum drawdown

1.78

1.69

+0.09

Martin ratioReturn relative to average drawdown

3.62

2.34

+1.29

GPCR vs. ABAT - Sharpe Ratio Comparison

The current GPCR Sharpe Ratio is 0.92, which is comparable to the ABAT Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of GPCR and ABAT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GPCR vs. ABAT - Drawdown Comparison

The maximum GPCR drawdown since its inception was -80.96%, smaller than the maximum ABAT drawdown of -93.56%. Use the drawdown chart below to compare losses from any high point for GPCR and ABAT.


Loading charts...

Drawdown Indicators


GPCRABATDifference

Max Drawdown

Largest peak-to-trough decline

-80.96%

-93.56%

+12.60%

Max Drawdown (1Y)

Largest decline over 1 year

-61.74%

-77.85%

+16.11%

Max Drawdown (3Y)

Largest decline over 3 years

-80.96%

Current Drawdown

Current decline from peak

-51.48%

-75.17%

+23.69%

Average Drawdown

Average peak-to-trough decline

-42.12%

-77.62%

+35.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.31%

56.15%

-25.84%

Volatility

GPCR vs. ABAT - Volatility Comparison

The current volatility for Structure Therapeutics Inc. American Depositary Shares (GPCR) is 14.06%, while American Battery Technology Company Common Stock (ABAT) has a volatility of 40.44%. This indicates that GPCR experiences smaller price fluctuations and is considered to be less risky than ABAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GPCRABATDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.06%

40.44%

-26.38%

Volatility (6M)

Calculated over the trailing 6-month period

42.67%

70.90%

-28.23%

Volatility (1Y)

Calculated over the trailing 1-year period

119.30%

132.17%

-12.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

98.52%

122.32%

-23.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

98.52%

122.32%

-23.80%

Dividends

GPCR vs. ABAT - Dividend Comparison

Neither GPCR nor ABAT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

GPCR vs. ABAT - Financials Comparison

This section allows you to compare key financial metrics between Structure Therapeutics Inc. American Depositary Shares and American Battery Technology Company Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00M4.00M6.00M8.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
7.81M
(GPCR) Total Revenue
(ABAT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


GPCR and ABAT have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABAT has higher volatility (40.44%) compared to GPCR (14.06%). In terms of maximum drawdown, GPCR dropped -80.96% vs ABAT's -93.56%.

ABAT currently has the higher Sharpe Ratio (1.00 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GPCR and ABAT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer